Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

C-Rad

27.70 SEK

-0.89 %

Less than 1K followers

CRAD B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-0.89 %
-14.37 %
-13.30 %
-20.17 %
-20.86 %
-13.17 %
-23.80 %
-50.62 %
+113.33 %

C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.

Read more
Market cap
935.34M SEK
Turnover
265.74K SEK
Revenue
441.9M
EBIT %
10.21 %
P/E
89.35
Dividend yield-%
0.36 %
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
3/3
2026

Extraordinary general meeting '26

6/5
2026

Interim report Q1'26

7/5
2026

General meeting '26

All
Research
Webcasts
Press releases
3rd party
ShowingAll content types
Regulatory press release2/16/2026, 8:30 AM

Återköp av aktier av C-RAD AB (publ) under vecka 7, 2026

C-Rad
C-RAD, Audiocast, Q4'25
Webcast2/12/2026, 10:00 AM

C-RAD, Audiocast, Q4'25

C-Rad
Regulatory press release2/12/2026, 7:00 AM

C-RADs Bokslutskommuniké Q4'25

C-Rad

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2/12/2026, 7:00 AM

C-RAD's Year-end report Q4'25

C-Rad
Regulatory press release2/9/2026, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 6, 2026

C-Rad
Regulatory press release2/2/2026, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 5, 2026

C-Rad
Press release1/29/2026, 7:00 AM

Inbjudan till presentation av C-RADs bokslutskommuniké samt rapport för fjärde kvartalet 2025

C-Rad
Press release1/29/2026, 7:00 AM

Invitation to presentation of C-RAD’s year-end report and report for the fourth quarter 2025

C-Rad
Regulatory press release1/28/2026, 2:45 PM

KALLELSE TILL EXTRA BOLAGSSTÄMMA I C-RAD AB (PUBL)

C-Rad
Regulatory press release1/26/2026, 1:25 PM

Tomas Blomquist utses till ny VD för C-RAD

C-Rad
Regulatory press release1/26/2026, 1:25 PM

Tomas Blomquist appointed new CEO of C-RAD

C-Rad
Regulatory press release1/26/2026, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 4, 2026

C-Rad
Regulatory press release1/19/2026, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 3, 2026

C-Rad
Regulatory press release1/12/2026, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 2, 2026

C-Rad
Regulatory press release1/5/2026, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 1, 2026

C-Rad
Regulatory press release12/29/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 52, 2025

C-Rad
Regulatory press release12/22/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 51, 2025

C-Rad
Regulatory press release12/15/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 50, 2025

C-Rad
Regulatory press release12/8/2025, 7:00 AM

Återköp av aktier av C-RAD AB (publ) under vecka 49, 2025

C-Rad
Regulatory press release12/1/2025, 12:02 PM

Finansinspektionen: Flaggningsmeddelande i C-Rad AB

C-Rad
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.